Publications 2018


2018 : 42 publications !


Arcaini L, Lamy T, Walewski J, Belada D, Mayer J, Radford J, Jurczak W, Morschhauser F, Alexeeva J, Rule S, Cabecadas J, Campo E, Pileri SA, Biyukov T, Patturajan M, Casadebaig Bravo ML, Trneny M, 2018. Prospective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator’’s choice in relapsed or refractory mantle cell lymphoma. Br. J. Haematol. 180, 224–235.

Barbieux S, Boyle EM, Baillet C, Demarquette H, Vermersch P, Morschhauser F, Herbaux C, 2018. Acute polyradiculopathy secondary to idelalisib in Relapsed Classical Hodgkin’’s lymphoma. Curr Res Transl Med. 

Barnoud D, Pinçon C, Bruno B, Béné J, Gautier S, Lahoche A, Petitpain N, Vasseur M, Barthélémy C, Décaudin B, Simon N, Odou P, 2018. Acute kidney injury after high dose etoposide phosphate: A retrospective study in children receiving an allogeneic hematopoetic stem cell transplantation. Pediatr Blood Cancer. 

Beauvais D, Goossens JF, Boyle E, Allal B, Lafont T, Chatelut E, Herbaux C, Morschhauser F, Genay S, Odou P, Danel C, 2018. Development and validation of an UHPLC-MS/MS method for simultaneous quantification of ibrutinib and its dihydrodiol-metabolite in human cerebrospinal fluid. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 1093–1094, 158–166. 

Belaiche S, Decaudin B, Dharancy S, Gautier S, Noel C, Odou P, Hazzan M, 2018. Factors associated with the variability of calcineurin inhibitor blood levels in kidney recipients grafted for more than 1 year. Fundam. Clin. Pharmacol. 32, 88–97. 

Benlabed M, Martin Mena A, Gaudy R, Perez M, Genay S, Hecq JD, Odou P, Lebuffe G, Décaudin B, 2018a. Analysis of particulate exposure during continuous drug infusion in critically ill adult patients: a preliminary proof-of-concept in vitro study. Intensive Care Med Exp 6, 38. 

Benlabed M, Perez M, Gaudy R, Genay S, Lannoy D, Barthélémy C, Odou P, Lebuffe G, Décaudin B, 2018b. Clinical implications of intravenous drug incompatibilities in critically ill patients. Anaesth Crit Care Pain Med. 

Besson A, Baillet C, Herbaux C, Foucher C, Lambilliotte A, Morschhauser F, Huglo D, 2018. Variability of hepatic SUVs and SULs in response assessment of avid FDG lymphoma during chemotherapy. Med. Nucl.-Imag. Fonct. Metab. 42, 114–124. 

Blasco H, Patin F, Descat A, Garçon G, Corcia P, Gelé P, Lenglet T, Bede P, Meininger V, Devos D, Gossens JF, Pradat PF, 2018. A pharmaco-metabolomics approach in a clinical trial of ALS: Identification of predictive markers of progression. PLoS ONE 13, e0198116. 

Bollier M, Klupsch F, Six P, Dubuquoy L, Azaroual N, Millet R, Leleu-Chavain N, 2018. One- or Two-Step Synthesis of C-8 and N-9 Substituted Purines. J. Org. Chem. 83, 422–430. 

Bouthors AS, Hennart B, Jeanpierre E, Baptiste AS, Saidi I, Simon E, Lannoy D, Duhamel A, Allorge D, Susen S, 2018. Therapeutic and pharmaco-biological, dose-ranging multicentre trial to determine the optimal dose of TRAnexamic acid to reduce blood loss in haemorrhagic CESarean delivery (TRACES): study protocol for a randomised, double-blind, placebo-controlled trial. Trials 19. 

Caiazzo R, Baud G, Clément G, Lenne X, Torres F, Dezfoulian G, Lebuffe G, Kipnis E, Dervaux B, Pattou F, 2018. Impact of Centralized Management of Bariatric Surgery Complications on 90-day Mortality. Ann. Surg. 

Catry E, Bindels LB, Tailleux A, Lestavel S, Neyrinck AM, Goossens JF, Lobysheva I, Plovier H, Essaghir A, Demoulin JB, Bouzin C, Pachikian BD, Cani PD, Staels B, Dessy C, Delzenne NM, 2018. Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction. Gut 67, 271–283. 

Cuvelier E, Mequinion M, Leghay C, Sibran W, Stievenard A, Sarchione A, Bonte MA, Vanbesien-Mailliot C, Viltart O, Saitoski K, Caron E, Labarthe A, Comptdaer T, Semaille P, Carrie H, Mutez E, Gressier B, Destee A, Chartier-Harlin MC, Belarbi K, 2018. Overexpression of Wild-Type Human Alpha-Synuclein Causes Metabolism Abnormalities in Thy1-aSYN Transgenic Mice. Front. Molec. Neurosci. 11. 

Decanter C, Robin G, Mailliez A, Sigala J, Morschhauser F, Ramdane N, Devos P, Dewailly D, Leroy-Martin B, Keller L, 2018. Prospective assessment of follicular growth and the oocyte cohort after ovarian stimulation for fertility preservation in 90 cancer patients versus 180 matched controls. Reprod. Biomed. Online. 

Decroix L, Tonoli C, Lespagnol E, Balestra C, Descat A, Drittij-Reijnders MJ, Blackwell JR, Stahl W, Jones AM, Weseler AR, Bast A, Meeusen R, Heyman E, 2018. One week CF intake increases prefrontal cortex oxygenation at rest and during moderate-intensity exercise in normoxia and hypoxia. J. Appl. Physiol. 

Domenger D, Cudennec B, Kouach M, Touche V, Landry C, Lesage J, Gosselet F, Lestavel S, Goossens JF, Dhulster P, Ravallec R, 2018. Food-Derived hemorphins cross intestinal and Blood-Brain Barriers In Vitro. Front. Endocrinol. 9. 

Ducloy-Bouthors AS, Jeanpierre E, Saidi I, Baptiste AS, Simon E, Lannoy D, Duhamel A, Allorge D, Susen S, Hennart B, 2018. TRAnexamic acid in hemorrhagic CESarean section (TRACES) randomized placebo controlled dose-ranging pharmacobiological ancillary trial: study protocol for a randomized controlled trial. Trials 19. 

Federico M, Barrigon MDC, Marcheselli L, Tarantino V, Manni M, Sarkozy C, Alonso-Alvarez S, Wondergem M, Cartron G, Lopez-Guillermo A, Issa D, Morschhauser F, Alcoceba M, Kimby E, Rusconi C, Chamuleau M, Holte H, Lockmer S, Montoto S, da Silva MG, Aurer I, Zucca E, Paszkiewicz-Kozik E, Minoia C, Skrypets T, Blaker YN, Salles G, Coiffier B, 2018. Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis. Lancet Haematol. 5, E359–E367. 

Ferret L, Ficheur G, Delaviez E, Luyckx M, Quenton S, Beuscart R, Chazard E, Beuscart JB, 2018.

Inappropriate anticholinergic drugs prescriptions in older patients: analysing a hospital database. Int. J. Clin. Phar,. 40, 94–100. 

Flamme-Obry F, Belaiche S, Hazzan M, Ramdan N, Noël C, Odou P, Décaudin B, 2018. [Clinical pharmacist and medication reconciliation in kidney transplantation]. Nephrol. Ther. 

Foulon C, Di Giulio P, Lecoeur M, 2018.

Simultaneous determination of inorganic anions and cations by supercritical fluid chromatography using evaporative light scattering detection. J. Chromatogr. A 1534, 139–149. 


Gelli M, Allard MA, Farges O, Paugam-Burtz C, Mabrut JY, Regimbeau JM, Vibert E, Boleslawski E, 2018. Use of aspirin and bleeding-related complications after hepatic resection. Br J Surg. 


Gibault F, Coevoet M, Sturbaut M, Farce A, Renault N, Allemand F, Guichou JF, Drucbert AS, Foulon C, Magnez R, Thuru X, Corvaisier M, Huet G, Chavatte P, Melnyk P, Bailly F, Cotelle P, 2018. Toward the Discovery of a Novel Class of YAPTEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAPTEAD ProteinProtein Interface. Cancers (Basel) 10. 

Gilliot S, Sibon I, Mas JL, Moulin T, Béjot Y, Cordonnier C, Giroud M, Odou P, Bordet R, Vivien D, Leys D, 2018.

Influence of on-going treatment with angiotensin-converting enzyme inhibitor or angiotensin receptor blocker on the outcome of patients treated with intravenous rt-PA for ischemic stroke. J. Neurol. 


Herbaux C, Merryman R, Devine S, Armand P, Houot R, Morschhauser F, Haverkos B, 2018. Recommendations for managing PD-1 blockade in the context of allogeneic HCT in Hodgkin lymphoma: taming a necessary evil. Blood. 

Jannin A, Turpin A, Baillet C, Aubert S, Do Cao C, 2018. High 18F-FDG Avidity of Low-Grade Esthesioneuroblastoma. Clin. Nucl. Med. 43, e101–e102.

Masse M, Maton M, Genay S, Blanchemain N, Barthélémy C, Décaudin B, Odou P, 2018. In vitro assessment of the influence of intravenous extension set materials on insulin aspart drug delivery. PLoS ONE 13, e0201623. 

Morschhauser F, Dekyndt B, Baillet C, Barthélémy C, Malek E, Fulcrand J, Bigot P, Huglo D, Décaudin B, Simon N, Odou P, 2018a. Y-ibritumomab tiuxetan based on 3-dimensional dosimetry. Sci Rep 8, 14860. 

Morschhauser F, Fowler NH, Feugier P, Bouabdallah R, Tilly H, Palomba ML, Fruchart C, Libby EN, Casasnovas RO, Flinn IW, Haioun C, Maisonneuve H, Ysebaert L, Bartlett NL, Bouabdallah K, Brice P, Ribrag V, Daguindau N, Le Gouill S, Pica GM, Martin Garcia-Sancho A, López-Guillermo A, Larouche JF, Ando K, Gomes da Silva M, André M, Zachée P, Sehn LH, Tobinai K, Cartron G, Liu D, Wang J, Xerri L, Salles GA, 2018b. Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma. N. Engl. J. Med. 379, 934–947. 

Morschhauser F, Salles G, Le Gouill S, Tilly H, Thieblemont C, Bouabdallah K, Fabiani B, Ménard C, Tarte K, Cartron G, Houot R, 2018c. An open-label, phase Ib study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma. Blood. 


Perez M, Décaudin B, Abou Chahla W, Nelken B, Storme L, Masse M, Barthélémy C, Lebuffe G, Odou P, 2018. Effectiveness of in-Line Filters to Completely Remove Particulate Contamination During a Pediatric Multidrug Infusion Protocol. Sci Rep 8, 7714. 

Robert L, Ficheur G, Décaudin B, Gellens J, Luyckx M, Perichon R, Gautier S, Puisieux F, Chazard E, Beuscart JB, 2018.

Hospital-acquired hyperkalemia events in older patients are mostly due to avoidable, multifactorial, adverse drug reactions. Clin. Pharmacol. Ther. 


Rossi C, Gilhodes J, Maerevoet M, Herbaux C, Morschhauser F, Brice P, Garciaz S, Borel C, Ysebaert L, Obéric L, Lazarovici J, Deau B, Dupuis J, Chauchet A, Abraham J, Bijou F, Stamatoullas-Bastard A, Malfuson JV, Golfier C, Laurent C, Pericart S, Traverse-Glehen A, Kanoun S, Filleron T, Casasnovas RO, Ghesquières H, 2018. Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory Hodgkin lymphoma: A series from Lysa centers. Am. J. Hematol. 

Simon N, Barnoud D, Bruno B, Vasseur M, Béné J, Odou P, 2018. Should we replace etoposide phosphate by etoposide for allogeneic hematopoetic stem-cell transplantation in children? Pediatr Blood Cancer. 


Tilly H, Morschhauser F, Casasnovas O, Molina TJ, Feugier P, Le Gouill S, Haioun C, Tournilhac O, Bouabdallah R, Gabarre J, Lamy T, Cabecadas J, Becker S, Jardin F, Mounier N, Salles G, 2018a. Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study.

Lancet Haematol. 5, E403–E410. 

Tilly H, Salles G, Molina TJ, Casasnovas RO, Morschhauser F, Coiffier B, 2018b. Through the Glass Ceiling. J. Clin. Oncol. JCO2017763961. 

Van den Neste E, André M, Gastinne T, Stamatoullas A, Haioun C, Belhabri A, Reman O, Casasnovas O, Guesquieres H, Verhoef G, Claessen MJ, Poirel HA, Copin MC, Dubois R, Vandenberghe P, Stoian IA, Cottereau AS, Bailly S, Knoops L, Morschhauser F, 2018. Phase II study of oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma. Haematologica. 

Vasseur M, Simon N, Picher C, Richeval C, Soichot M, Humbert L, Barthélémy C, Fleury-Souverain S, Bonnabry P, Décaudin B, Allorge D, Odou P, 2018. A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study. PLoS ONE 13, e0201335. 


Vo DN, Alexia C, Allende-Vega N, Morschhauser F, Houot R, Menard C, Tarte K, Cartron G, Villalba M, 2018. NK cell activation and recovery of NK cell subsets in lymphoma patients after obinutuzumab and lenalidomide treatment. OncoImmunology 7. 

Walther J, Nivoix Y, Vigouroux D, Simon N, Debry C, Gourieux B, 2018.

Improvement of drugs prescription and administration through enteral feeding tubes during hospitalization and before discharge to home. Nutr. Clin. Metab. 32, 113–121.

Zimmermann H, Babel N, Dierickx D, Morschhauser F, Mollee P, Zaucha JM, Dreyling MH, Dührsen U, Reinke P, Verhoef G, Subklewe M, Hüttmann A, Tousseyn T, Bachy E, Hauser IA, Tarella C, Van Den Neste E, Gheysens O, Anagnostopoulos I, Leblond V, Riess H, Choquet S, Trappe RU, 2018. Immunosuppression is associated with clinical features and relapse risk of B cell posttransplant lymphoproliferative disorder: A retrospective analysis based on the prospective, international, multicenter PTLD-1 trials. Transplantation.